** Shares of IDT Australia RIC rise 8.9% to A$0.098; marks biggest intraday percentage gain since January 28
** The pharma manufacturer secures manufacturing contract with Nacuity Pharmaceuticals Pty for NPI-001, an investigational treatment for retinitis pigmentosa
** Five-year contract with initial A$3.2 million ($1.91 million) work expected to complete by FY2026, adds co
** Stock down 18.2% this year, as of last close
($1 = 1.6753 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。